Overview
SNY market data
Price History
SNY price chart · 1M
- O
- 44.27
- H
- 44.31
- L
- 44.03
- C
- 44.23
- Vol
- 88,971.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $44.27
- Previous Close
- $44.32
- Day High
- $44.31
- Day Low
- $44.03
- 52 Week High
- $46.11
- 52 Week Low
- $40.90
- 7 Day Return
- -1.32%
- 30 Day Return
- +3.37%
- 90 Day Return
- +0.77%
- 1 Year Return
- +4.08%
- Daily Notional Volume
- $3.9M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 23.38 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $6.37 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.76 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 4.1% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 8.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $71.25 – $91.15 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $92.6B · P/B 1.41 · P/S 1.89.
Company News
10 captured
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?Zacks Investment Research ·
Eli Lilly to Buy Immunology Biotech Merida Biosciences in $2.9B DealZacks Investment Research ·
$7+ Billion mRNA Vaccines Market Outlook, 2035: Opportunities, Strategies, ChallengesGlobenewswire Inc ·